WWW.DISSERTATION.XLIBX.INFO
FREE ELECTRONIC LIBRARY - Dissertations, online materials
 
<< HOME
CONTACTS



Pages:   || 2 |

«BUSPIRONE HYDROCHLORIDE HYDROCHLORIDE TABLETS 5/10/15/30MG Material Safety Data Sheet 1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION Product name: ...»

-- [ Page 1 ] --

BUSPIRONE HYDROCHLORIDE

HYDROCHLORIDE

TABLETS 5/10/15/30MG

Material Safety Data Sheet

1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

Product name: Buspirone Hydrochloride Tablets USP

Material Name: Buspirone Hydrochloride

Chemical formula of active ingredient: C21H31N5O2 • HCl

Chemical name of active ingredient: 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]-butyl]-8-azaspiro [4,5] decane-7,9- dione monohydrochloride How supplied: 5 mg, 10mg, 15mg & 30mg Use: Anti-anxiety Supplier of Data: Strides Arcolab Ltd Opposite to IIMB, Bilekahalli Bangalore – 560076 India For emergency or Product information, call 1 877 244 9825

2. COMPOSITION/INFORMATION ON INGREDIENTS

Product contains excipients: Colloidal silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose and sodium starch glycolate.

3. HAZARDS IDENTIFICATION

EMERGENCY OVERVIEW:

Product Description: Buspirone Hydrochloride Tablets, USP are available as:

Buspirone Hydrochloride Tablets, USP 5 mg are White to off white ovoid- rectangular uncoated tablet with score line on one side and engraved ‘5’ on the other side. Tablets are packed in the bottles of 100 having NDC 64380-741-06.

Buspirone Hydrochloride Tablets, USP 10 mg are White to off white ovoid - rectangular uncoated tablet with score line on one side and engraved ‘10’ on the other side. Tablets are packed in the bottles of 100 having NDC 64380-742-06.

Buspirone Hydrochloride Tablets, USP 15 mg are White to off white rectangular uncoated tablet with trisected score lines on one side and trisected score line with engraved ‘5’ on each trisection of other 1

BUSPIRONE HYDROCHLORIDE

HYDROCHLORIDE

TABLETS 5/10/15/30MG Material Safety Data Sheet side. The 15 mg tablet is in xx tablet design and scored so that it can be either bisected or trisected.

Tablets are packed in bottles of 60 having NDC 64380-743-03, 100 having NDC 64380-743-06 and 180 having NDC 64380-743-18.

Buspirone Hydrochloride Tablets, USP 30 mg are White to off white rectangular uncoated tablet with trisected score lines on one side and trisected score line with engraved ‘10’ on each trisection of other side. Tablets are packed in bottles of 60 having NDC 64380-744-03.

Store at 20 °C to 25 °C (68 ° to 77 °F); excursions permitted between 15 °C to 30 °C (59 °F to 86 °F) [see USPcontrolled room temperature].

Health Hazards: The chief health hazard associated with overexposures during normal use and handling is the potential for irritation of contaminated skin. Individuals who have had allergic reactions to products containing Buspirone Hydrochloride or any of the other ingredients in this product may experience allergic reactions to this product. Therapeutic use of Buspirone Hydrochloride can cause adverse symptoms of the central nervous system, gastrointestinal system, and skin.

Flammability Hazards: If heated to high temperatures for a prolonged period, the product may ignite.

When involved in a fire, this material may decompose and produce irritating vapors and toxic compounds (including carbon oxides, nitrogen oxides, sodium oxides, magnesium oxides, sodium oxides, and hydrogen chloride).

Reactivity Hazards: This product is not reactive.

Environmental Hazards: Large quantities released to the aquatic and terrestrial environment may have an adverse effect.

Emergency Considerations: Emergency responders should wear appropriate protection for the situation to which they respond.

SYMPTOMS OF OVEREXPOSURE BY ROUTE OF EXPOSURE: The health hazard information provided below is pertinent to medical employees using this product in an occupational setting. The following paragraphs describe the symptoms of exposure by route of exposure.

INHALATION: Inhalation of airborne dusts generated by this product may slightly irritate the nose, throat, and lungs. Symptoms may include coughing, sneezing, and difficulty breathing.

CONTACT WITH SKIN or EYES: Contact with the skin may cause mild irritation, which is alleviated upon rinsing. Prolonged or reaped skin contact may cause dermatitis (dry, red skin). Contact with the eyes of airborne dusts generated by this product may cause mild eye irritation.

2

BUSPIRONE HYDROCHLORIDE

HYDROCHLORIDE

TABLETS 5/10/15/30MG Material Safety Data Sheet SKIN ABSORPTION: This product and its components are not known to be absorbed through intact skin.

INGESTION: Ingestion is not a significant route of occupational overexposure. Acute ingestion of large quantities of this product caused by poor hygiene practices can cause nausea, vomiting, dizziness, drowsiness, pupil constriction, and gastric distress. Symptoms of prolonged or repeated ingestion, as may occur when poor industrial hygiene is practiced, may include those described for ―Other Potential Health Effects‖. Individuals who have had allergic reactions to products containing Buspirone Hydrochloride or any of the other ingredients in this product may experience allergic reactions to this product.





INJECTION: Though not anticipated to be a significant route of overexposure for this product, injection (via punctures or lacerations by contaminated objects) may cause redness at the site of injection.

OTHER POTENTIAL HEALTH EFFECTS-Therapeutic Doses: Employees administering the product should not experience adverse effects if handled properly. Adverse effects from therapeutic doses

have included the following:

Dizziness, drowsiness, nervousness, insomnia, lightheadedness, difficulty concentrating, excitement, anger, hostility, confusion, and depression.

Rapid heartbeat and palpitations.

Blurred vision.

Nausea, dry mouth, gastric distress, diarrhea, constipation, and vomiting.

Muscle and joint pain.

Numbness, incoordination, tremor, and burning, prickling, itching, or tingling of the skin.

Rash.

Headache, fatigue, weakness, sweating, and clamminess.

HEALTH EFFECTS OR RISKS FROM EXPOSURE: An Explanation in Lay Terms. Overexposure

to this product may cause the following health effects:

ACUTE: The primary health effects that may be experienced by medical personnel exposed to this product is mild irritation of contaminated skin.

CHRONIC: Repeated skin contact may cause dermatitis (dry, red skin). In the event of acute or chronic exposures to therapeutic doses of this product, effects described in ―Other Potential Health Effects‖ may result. See Section 11 (Toxicological Information, for additional information).

3

BUSPIRONE HYDROCHLORIDE

HYDROCHLORIDE

TABLETS 5/10/15/30MG Material Safety Data Sheet TARGET ORGANS: ACUTE: Industrial Exposure: Skin, eyes. Therapeutic Doses: Central nervous system and gastrointestinal system. CHRONIC: Industrial Exposure: Skin. Therapeutic Doses: Central nervous system, gastrointestinal system, and skin.

4. FIRST AID MEASURES Persons developing hypersensitivity reactions should receive medical attention. If breathing is difficult, give oxygen. If not breathing, give artificial respiration. Take a copy of label and MSDS to physician or health professional with the contaminated individual.

SKIN EXPOSURE: Basic hygiene should prevent any problems. If the product contaminates the skin, immediately begin decontamination with running water. Remove exposed or contaminated clothing, taking care not to contaminate eyes. The minimum recommended flushing time is 15 minutes. Victims must seek immediate medical attention, especially if an adverse reaction occurs.

EYE EXPOSURE: If airborne dusts generated by this product enter the eyes, open victim's eyes while under gently running water. Use sufficient force to open eyelids and then "roll" while flushing eyes.

Minimum flushing is for 15 minutes if the exposure has resulted in an adverse effect. The contaminated individual must seek medical attention if any adverse effect continues after rinsing.

INHALATION: If airborne dusts generated by this product are inhaled, remove victim to fresh air. If necessary, use artificial respiration to support vital functions. Seek medical attention if adverse effect continues after removal to fresh air.

INGESTION: If this product is swallowed, CALL PHYSICIAN OR POISON CONTROL CENTER FOR MOST CURRENT INFORMATION. If professional advice is not available, do not induce vomiting. Never induce vomiting or give diluents (milk or water) to someone who is unconscious, having convulsions, or unable to swallow. If victim is convulsing, maintain an open airway and obtain immediate medical attention.

MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE: Hypersensitivity to Buspirone Hydrochloride and central nervous system disorders may be aggravated by chronic overexposures to this product.

RECOMMENDATIONS TO PHYSICIANS: This product should only be given to patients by persons experienced in management of patients receiving the type of therapy intended for this product. General symptomatic and supportive measures should be used along with immediate gastric lavage. Respiration, pulse, and blood pressure should be monitored as in all cases of drug overdosage. No specific antidote is

–  –  –

5. FIRE-FIGHTING MEASURES FLASH POINT: Not established.

AUTOIGNITION TEMPERATURE: Not established.

FLAMMABLE LIMITS (in air by volume, %):

Lower (LEL): Not applicable.

Upper (UEL): Not applicable.

FIRE EXTINGUISHING MATERIALS: Use extinguishing media appropriate for surrounding fire.

Water Spray: OK Carbon Dioxide: OK Dry Chemical: OK Halon: OK Foam: OK Other: Any "ABC" Class UNUSUAL FIRE AND EXPLOSION HAZARDS: This product may ignite if highly heated for a prolonged period of time. When involved in a fire, the products of thermal decomposition may include irritating fumes and toxic gases (e.g., carbon oxides, nitrogen oxides, sodium oxides, magnesium oxides, sodium oxides, and hydrogen chloride). Explosion Sensitivity to Mechanical Impact: Not sensitive.

Explosion Sensitivity to Static Discharge: Not sensitive.

SPECIAL FIRE-FIGHTING PROCEDURES: Incipient fire responders should wear eye protection.

Structural firefighters must wear Self-Contained Breathing Apparatus (SCBA) and full protective equipment. If protective equipment is contaminated by this product, it should be thoroughly washed with running water prior to removal of SCBA respiratory protection. Firefighters whose protective equipment becomes contaminated should thoroughly shower with warm, soapy water and should receive medical evaluation if they experience any adverse effects.

6. ACCIDENTAL RELEASE MEASURES

SPILL RESPONSE: For small releases of this compound (1 bottle), take basic hygiene precautions.

Lightweight gloves, a lab coat, and eye protection should be worn. Pick up or sweep up spilled tablets, place in a bag, and hold for waste disposal. Avoid generating airborne dusts of this product during cleanup. In case of a large spill, clear the affected area and protect people. Large or uncontrolled releases 5

BUSPIRONE HYDROCHLORIDE

HYDROCHLORIDE

TABLETS 5/10/15/30MG Material Safety Data Sheet (a case of bottles) should be responded to by trained personnel using pre-planned procedures. Proper protective equipment should be used, including lab gloves, full body gown, boots, and splash goggles.

Respiratory protection should not be necessary. Pick up or sweep up spilled tablets. Decontaminate the area of the spill thoroughly using detergent and water. Place all spill residue in an appropriate container and seal. Dispose of in accordance with appropriate U.S. Federal, State, and local regulations or with regulations of the EU and its member states or Canada and its Provinces.

7. HANDLING AND STORAGE WORK PRACTICES AND HYGIENE PRACTICES: As with all chemicals, avoid getting this product ON YOU or IN YOU. Do not eat, drink, smoke, or apply cosmetics while handling this product.

Wash hands thoroughly after handling this product or equipment and containers that contain this product.

Follow SPECIFIC USE INSTRUCTIONS supplied with this product. Particular care in working with this product must be practiced in pharmacies and other preparation areas, during manufacture of this compound, and during patient administration. Use of this product should meet the provisions outlined as

follows:

Work should be performed in an appropriate, designated area;

Contaminated waste must be properly handled; and, If necessary, work areas must be regularly decontaminated.

STORAGE AND HANDLING PRACTICES: Employees must be trained to properly use this product.

Use of this product should be performed in a designated area for working with drugs. Ensure product is properly labelled. Store this product away from incompatible materials. Store this product in original container. Inspect bottles containing this product for leaks or damage. This product must be stored in a locked cabinet in a Controlled Substance Storage Room, per the requirements of regulations of the DEA and FDA.

PRODUCT PREPARATION INSTRUCTIONS FOR MEDICAL PERSONNEL: Handle this material following standard medical practices and following the recommendations presented on the Package Insert.

PROTECTIVE PRACTICES DURING MAINTENANCE OF CONTAMINATED EQUIPMENT:

When cleaning non-disposable equipment, wear latex or butyl rubber gloves (double gloving is recommended), goggles, and lab coat. Wash equipment with soap and water. Wipe equipment down with damp sponge or polypad.

–  –  –

Protective clothing and equipment:

Wear gloves to prevent skin contact. Wash hands with soap and water whenever gloves are removed.



Pages:   || 2 |


Similar works:

«UNITED STATES BANKRUPTCY COURT FOR THE WESTERN DISTRICT OF MICHIGAN In re: Case No. DG 11-05409 JALAL PARIROKH, fdba LEILA, LLC, Hon. Scott W. Dales fdba HULK, LLC, fdba VIDEO MASTER, Chapter 7 fdba ELBIFA, LLC, fdba ARTEMISIA, LLC, Debtor. _/ MEMORANDUM OF DECISION AND ORDER REGARDING APPLICATION TO RETAIN COUNSEL PRESENT: HONORABLE SCOTT W. DALES United States Bankruptcy Judge I. INTRODUCTION Thomas A. Bruinsma (the “Trustee”) commenced suit against the Debtor’s estranged wife, Iryna...»

«A FOCUS THEORY OF NORMATIVE CONDUCT: A THEORETICAL REFINEMENT AND REEVALUATION OF THE ROLE OF NORMS IN HUMAN BEHAVIOR Robert B. Cialdini Carl A. Kallgren Raymond R. Reno During the past two decades, the state of the natural environment has become an increasingly important concern in our society. Consequently, public and private groups at the local, state, and national levels have undertaken a wide variety of programs designed to discourage behaviors that damage or despoil the environment. One...»

«Escuela de Formación. Curso nº 64 Manual para alumno y alumna Resolución positiva de conflictos cotidianos en la familia ¿Os gustaría dejar de gritar a vuestros hijos e hijas? ¿Consideráis importante fomentar la responsabilidad de vuestros hijos junto a su felicidad? ¿Creéis posible que podáis conseguir reducir vuestros enfados y regañinas? ¿Cómo afrontáis los conflictos con vuestros hijos e hijas? ¿Cómo podemos decir NO a nuestros hijos e hijas de una manera amable pero firme?...»

«CONFERENCE ABSTRACTS International Conference on Archaeology and Cultural Heritage in Pakistan and Adjacent Regions Islamabad, Jan 5-8, 2012 Sponsored by the American Institute of Pakistan Studies with support from the US Embassy, Islamabad In collaboration with the Department of Archaeology and Museums Ministry of National Heritage and Integration Government of Pakistan Radio Pakistan: Official Media Partner Archaeology  and  Cultural  Heritage  Conference:    Abstracts      ...»

«Improving Water Security for the future through IWRM and better Water Governance in the Red – Thai Binh river basin (Vietnam) By Nguyen Thuy Hang, Staff member Division for Science and Technology Institute of Water Resources Planning (Red-Thai Binh RBO Office) I. INTRODUCTION 1. Natural and socio-economic conditions The Red-Thai Binh river system is the second biggest in Vietnam (second to Mekong river system) but it is the biggest in term of area and water availability in Vietnam’s...»

«INTERNATIONAL JOURNAL OF GEOMATICS AND GEOSCIENCES Volume 4, No 1, 2013 © Copyright 2010 All rights reserved Integrated Publishing services ISSN 0976 – 4380 Research article Flood risk zone mapping of the Subansiri sub-basin in Assam, India Chinmoyee Gogoi1, Dulal C. Goswami2, Sarat Phukan3 1,2Department of Environmental Science 3Department of Geological Sciences Gauhati University, Guwahati – 781014, Assam, India chinmoyee.gogoi@gmail.com ABSTRACT Flood plain zoning of a river basin is an...»

«SCADA Questions and Answers By Dr. Jay Park SCADA System Evaluation Questions Revision 4, October 1, 2007 Table of Contents SCADA System Evaluation Questions Revision 4, October 1, 2007 Architecture Redundancy Configuration Graphics Alarms Trends Reports Performance Language Feature Questions Some additional important questions about protocols & vendors are as follows: Architecture Is this Control and Monitoring system supplied as a single package? Yes How much does each additional driver cost?...»

«A5 MINISTERO PER I BENI CULTURALI E AMBIENTALI SOPRINTENDENZA ARCHEOLOGICA DELLA TOSCANA SEZIONE DIDATTICA SCHEDA 5 CORREDI FUNERARI (Diapositive 76 110) Statuaria Gli Egiziani credevano che la statua di una persona o di un animale fosse in qualche modo animata: le divinità venivano infatti rese vive mediante le loro statue, che quotidianamente erano lavate, vestite e nutrite. L’idea della corrispondenza di una statua con la persona raffigurata era completata dall’iscrizione del nome sulla...»

«Abstract: The Four Assemblies and the Foundation of the Order of Nuns by Analayo According to the account of the foundation of the order of nuns, found with some variations in the different Vinayas preserved in Chinese, Pali, Sanskrit and Tibetan, the Buddha was quite hesitant to permit women to go forth and was persuaded by his monk disciple and attendant Ananda to do so only after repeated pleading. Not only was the Buddha unwilling to institute the order of nuns, but he supposedly even made...»

«IN THE SUPREME COURT OF MISSISSIPPI NO. 2005-DR-00523-SCT THONG LE v.STATE OF MISSISSIPPI DATE OF JUDGMENT: 08/23/2002 TRIAL JUDGE: HON. JAMES W. BACKSTROM COURT FROM WHICH APPEALED: JACKSON COUNTY CIRCUIT COURT ATTORNEYS FOR APPELLANT: MISSISSIPPI OFFICE OF CAPITAL POST CONVICTION COUNSEL BY: ROBERT M. RYAN LOUWLYNN VANZETTA WILLIAMS ATTORNEYS FOR APPELLEE: OFFICE OF THE ATTORNEY GENERAL BY: PAT MCNAMARA MARVIN L. WHITE, JR. DISTRICT ATTORNEY: KEITH MILLER NATURE OF THE CASE: CIVIL DEATH...»

«Int. J. Mol. Sci. 2013, 14, 19540-19555; doi:10.3390/ijms141019540 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Article Isolation and Characterization of Squamous Cell Carcinoma-Derived Stem-like Cells: Role in Tumor Formation Katiuscia Dallaglio 1,†, Tiziana Petrachi 1,†, Alessandra Marconi 1, Francesca Truzzi 1, Roberta Lotti 1, Annalisa Saltari 1, Paolo Morandi 1, Mario Puviani 2, Antonino Maiorana 3, Dennis R. Roop 4 and Carlo Pincelli...»

«Heffernan 1 STAGING ABSORPTION AND TRANSMUTING THE EVERYDAY: A RESPONSE TO MICHAEL FRIED James A. W. Heffernan In his recent essay on the photography of Jeff Wall (“Jeff Wall, Wittgenstein, and the Everyday,” Critical Inquiry 33 [Spring 2007]: 495-526), Michael Fried suggestively amplifies the account of pictorial absorption that he first gave us almost thirty years ago and that has since become a landmark in art criticism.1 But in showing how Wallby his own account meticulously stages his...»





 
<<  HOME   |    CONTACTS
2016 www.dissertation.xlibx.info - Dissertations, online materials

Materials of this site are available for review, all rights belong to their respective owners.
If you do not agree with the fact that your material is placed on this site, please, email us, we will within 1-2 business days delete him.